Decoding Liver Fibrosis: How Omics Technologies and Innovative Modeling Can Guide Precision Medicine

Area of Science:

• Cellular and Molecular Biology
• Hepatology
• Biotechnology

Background:

• Chronic liver disease (CLD) is a growing global health burden, affecting 20-30% of the world's population.
• Hepatic fibrosis, a common symptom of CLD, impairs liver function but is reversible if detected early.
• Current therapies for liver fibrosis are limited, necessitating research into underlying molecular mechanisms.

Purpose of the Study:

• To provide an overview of innovative omics technologies revolutionizing liver fibrosis research.
• To explore current cellular and organoid models for studying liver fibrosis pathophysiology.
• To highlight the potential of these tools for understanding disease mechanisms and advancing precision medicine.

Main Methods:

• Review of emerging cutting-edge fields in cellular and molecular biology.
• Focus on spatial and single-cell resolution approaches for detailed mechanistic insights.
• Discussion of cellular models, including induced pluripotent stem cells (iPSCs) and organoids.

Main Results:

• Innovative omics technologies are transforming liver fibrosis research.
• Advanced cellular models recapitulate liver fibrosis pathophysiology in vitro.
• These models aid in uncovering molecular mechanisms and serve as patient-specific avatars for precision medicine.

Conclusions:

• Spatial and single-cell resolution techniques offer unprecedented understanding of liver fibrosis.
• iPSC-derived organoids are powerful tools for modeling liver diseases and studying hepatic tissue heterogeneity.
• Further research utilizing these innovative technologies is crucial for developing effective fibrosis therapies.